Sage Journals: Discover world-class research

Open access

Case report

First published 2024

A rare adverse effect in inebilizumab therapy for neuromyelitis optica spectrum disorder: a case report

Xuefen Chen, Ziyan Shi, Rui Wang [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2021-11

Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD

Bruce AC Cree, Jeffrey L Bennett, Ho Jin Kim [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2022-5

Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4–immunoglobulin G–seropositive participants taking inebilizumab for ⩾4 years in the N-MOmentum trial

Mary Rensel, Aram Zabeti, Maureen A Mealy [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2019-2

Safety and tolerability of inebilizumab (MEDI-551),an anti-CD19 monoclonal antibody,in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised,placebo-controlled,escalating intravenous and subcutaneous dose study

Mark A Agius, Gabriela Klodowska-Duda, Maciej Maciejowski [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2023-7

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum

Brian G Weinshenker, Dean M Wingerchuk, Ari J Green [...]

Multiple Sclerosis Journal

Retricted access

Case report

First published 2023-10

Neuromyelitis Optica Spectrum Disorder Management in the Setting of Chronic Hepatitis B and Latent Tuberculosis: A Case Report

Dylan Sadowsky, Kevin Delijani, William Davis [...]

The Neurohospitalist

Open access

Review article

First published 2024-01

Advances in the long-term treatment of neuromyelitis optica spectrum disorder

Monique Anderson, Michael Levy

Journal of Central Nervous System Disease

Open access

Research article

First published 2025

Cellular and humoral vaccination response under immunotherapies—German consensus on vaccination strategies in neurological autoimmune diseases

Muriel Schraad, Mathias Mäurer, Anke Salmen [...]

Therapeutic Advances in Neurological Disorders

Search results